Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+1.14%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$2.1B
AUM Growth
-$855M
(-29%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-48.78%
Top 10 Holdings %
Top 10 Hldgs %
24.64%
Holding
3,616
New
552
Increased
444
Reduced
696
Closed
635
Top Buys
| 1 |
Alibaba
BABA
|
+$83.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$43.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$25M |
| 4 |
JPMorgan Chase
JPM
|
+$24.6M |
| 5 |
Netflix
NFLX
|
+$23.9M |
Top Sells
| 1 |
Cigna
CI
|
+$127M |
| 2 |
Microsoft
MSFT
|
+$75.9M |
| 3 |
Apple
AAPL
|
+$70.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$57.2M |
| 5 |
Scorpio Tankers
STNG
|
+$43.1M |
Sector Composition
| 1 | Technology | 24.87% |
| 2 | Consumer Discretionary | 17.15% |
| 3 | Financials | 10.98% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Charles River Laboratories
CRL
$7.75B
| $277K | ﹤0.01% |
1,372
-1,544
| -53% | -$312K |
|
602
Pliant Therapeutics
PLRX
$107M
| $276K | ﹤0.01% |
+10,372
| New | +$276K |
|
603
Zevra Therapeutics
ZVRA
$461M
| $275K | ﹤0.01% |
49,929
-26,068
| -34% | -$143K |
|
|
PDS
604
Precision Drilling
PDS
$753M
| $273K | ﹤0.01% |
5,318
+3,946
| +288% | +$203K |
|
|
TBHC
605
The Brand House Collective, Inc. Common Stock
TBHC
$44.9M
| $273K | ﹤0.01% |
95,795
+46,768
| +95% | +$133K |
|
606
CureVac
CVAC
$1.21B
| $272K | ﹤0.01% |
39,058
-10,501
| -21% | -$73.2K |
|
607
American Superconductor
AMSC
$2.25B
| $272K | ﹤0.01% |
55,423
+7,167
| +15% | +$35.2K |
|
608
Lamb Weston
LW
$7.96B
| $271K | ﹤0.01% |
+2,594
| New | +$271K |
|
609
Metropolitan Bank Holding Corp
MCB
$819M
| $270K | ﹤0.01% |
+7,958
| New | +$270K |
|
610
Sangamo Therapeutics
SGMO
$157M
| $269K | ﹤0.01% |
152,945
-19,204
| -11% | -$33.8K |
|
|
MAG
611
DELISTED
MAG Silver
MAG
| $267K | ﹤0.01% |
21,051
-81,159
| -79% | -$1.03M |
|
612
Northern Trust
NTRS
$24.6B
| $266K | ﹤0.01% |
+3,016
| New | +$266K |
|
613
ADMA Biologics
ADMA
$3.91B
| $265K | ﹤0.01% |
+80,127
| New | +$265K |
|
614
Encompass Health
EHC
$12.6B
| $263K | ﹤0.01% |
+4,870
| New | +$263K |
|
615
Takeda Pharmaceutical
TAK
$48.2B
| $263K | ﹤0.01% |
+15,938
| New | +$263K |
|
616
Ericsson
ERIC
$26.7B
| $260K | ﹤0.01% |
44,425
-170,768
| -79% | -$999K |
|
|
RXDX
617
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $260K | ﹤0.01% |
+2,421
| New | +$260K |
|
618
Alaska Air
ALK
$7.18B
| $256K | ﹤0.01% |
+6,112
| New | +$256K |
|
619
American Vanguard Corp
AVD
$153M
| $256K | ﹤0.01% |
11,715
+3,381
| +41% | +$74K |
|
620
iShares Gold Trust
IAU
$53.3B
| $256K | ﹤0.01% |
6,839
-8,698
| -56% | -$325K |
|
|
DCP
621
DELISTED
DCP Midstream, LP
DCP
| $255K | ﹤0.01% |
+6,118
| New | +$255K |
|
622
Crown Holdings
CCK
$11B
| $255K | ﹤0.01% |
+3,085
| New | +$255K |
|
|
EGLE
623
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $255K | ﹤0.01% |
+5,603
| New | +$255K |
|
624
Quanta Services
PWR
$55.6B
| $255K | ﹤0.01% |
+1,529
| New | +$255K |
|
625
Ecolab
ECL
$76.8B
| $252K | ﹤0.01% |
1,521
+575
| +61% | +$95.2K |
|